Drug Profile
Flumazenil subcutaneous - Go Medical Industries
Latest Information Update: 15 Mar 2022
Price :
$50
*
At a glance
- Originator Go Medical Industries
- Class Antidotes; Benzodiazepinones; Esters; Fluorine compounds; Imidazoles; Small molecules
- Mechanism of Action GABA-A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II/III Alcoholism
Most Recent Events
- 15 Mar 2022 Go Medical Industries terminates a phase II/III trial for Alcoholism (Alcohol withdrawal syndrome) in Australia before March 2022 due lack of funding, staff, facilities and participant recruitment difficulties (ACTRN12616001560482)
- 23 Feb 2022 Flumazenil subcutaneous is still in phase II/III trial in Alcoholism (Alcohol withdrawal syndrome) in Australia (SC) (ACTRN12617000039381)
- 15 Feb 2017 Chemical structure information added